| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Stroke, Vol 24, 1218-1226, Copyright © 1993 by American Heart Association
W Hollander, S Prusty, T Kemper, DL Rosene and MB Moss
BACKGROUND AND PURPOSE: There is substantial clinical, pathological, and
experimental evidence that hypertension aggravates atherosclerosis of the
extracranial vessels. The present study assesses the effects of
hypertension on the development of cerebral atherosclerosis in nonhuman
primates fed an atherogenic diet. METHODS: The extent and severity of
cerebral atherosclerosis were evaluated morphologically, morphometrically,
and biochemically in atherosclerotic monkeys with and without hypertension.
Atherosclerosis was induced by feeding a hypercholesterolemic diet for 12
months; hypertension was produced by surgical coarctation of the thoracic
aorta. RESULTS: At autopsy, gross atherosclerotic lesions of the major
cerebral arteries were observed in 15 of 16 atherosclerotic monkeys with
hypertension compared with 5 of 16 atherosclerotic animals without
hypertension. In the hypertensive- atherosclerotic group, 38.5% of the
vessels examined showed gross involvement compared with only 3.4% of the
vessels involved in the atherosclerotic group (P < .001). The lesions in
the atherosclerotic group were generally mild, whereas those in the
hypertensive- atherosclerotic group were severe and resulted in significant
luminal narrowing and occlusion of vessels (P < .001). The small
branches of the cerebral arteries also showed severe disease with luminal
obstruction in the hypertensive-atherosclerotic group. The extent and
severity of cerebral atherosclerosis were significantly related to the
severity of the hypertension (P < .05). CONCLUSIONS: Hypertension is an
important factor in cerebral atherosclerosis because of its accelerating
effect on the disease. Nonhuman primate models may be useful in clarifying
the role of hypertension and atherosclerosis in cerebral vascular disease.
ARTICLES
The effects of hypertension on cerebral atherosclerosis in the cynomolgus monkey
Department of Medicine, Boston University School of Medicine, MA 02118.
This article has been cited by other articles:
![]() |
A. G. Pockley Heat Shock Proteins, Inflammation, and Cardiovascular Disease Circulation, February 26, 2002; 105(8): 1012 - 1017. [Full Text] [PDF] |
||||
![]() |
A. G. Pockley, R. Wu, C. Lemne, R. Kiessling, Ulf de Faire, and J. Frostegard Circulating Heat Shock Protein 60 Is Associated With Early Cardiovascular Disease Hypertension, August 1, 2000; 36(2): 303 - 307. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Frostegard, R. Wu, C. Gillis-Haegerstrand, C. Lemne, and U. de Faire Antibodies to Endothelial Cells in Borderline Hypertension Circulation, September 15, 1998; 98(11): 1092 - 1098. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Frostegard, C. Lemne, B. Andersson, R. van der Zee, R. Kiessling, and U. de Faire Association of Serum Antibodies to Heat-Shock Protein 65 With Borderline Hypertension Hypertension, January 1, 1997; 29(1): 40 - 44. [Abstract] [Full Text] |
||||
|
Stroke Home | Subscriptions | Archives | Feedback | Authors | Help | AHA Journals Home | Search Copyright © 1993 American Heart Association, Inc. All rights reserved. Unauthorized use prohibited. |